Eric H Bernicker, MD

Assistant Professor of Clinical Medicine in Oncology, Institute for Academic Medicine
Assistant Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of SWOG trials, and industry trials of novel targeted agents. 

Description of Research

Dr. Bernicker’s research focuses on looking at different therapeutic approaches, such as targeted therapies and immunotherapies, in the treatment of lung cancer. By understanding how to identify patients at risk for relapse after surgery or those who can be spared the toxicities of chemotherapy, the immune system can be stimulated to preferentially destroy tumor cells, spare normal tissues, and improve patient survival along with the development of less toxic therapeutics. Eventually, the goal is to be able to offer new therapies and clinical trials to patients at Methodist with any stage of non-small cell lung cancer or small cell lung cancer.

Areas Of Expertise

Cancer research Lung cancer Targeted therapeutics
Education & Training

, Baylor College of Medicine
, Dallas County Hospital -Parkland Memorial Hospital
Publications

First-line immune therapy - Implications for pathologists
Miller, RA , Cagle, PT & Bernicker, EH 2016, Archives of Pathology and Laboratory Medicine, vol 140, no. 8, pp. 739-740. DOI:

Chemotherapy in non-small cell lung cancer: opportunities for advancement
Akhtari, M, Bernicker, EH & Teh, BS 2016, Chinese Journal of Lung Cancer, vol 35, no. 1, pp. 56. DOI:

Impact of recent developments in lung cancer on the practice of pathology
Cagle, PT, Allen, TC, Bernicker, EH, Ge, Y, Haque, A & Barrios, R 2016, Archives of Pathology and Laboratory Medicine, vol 140, no. 4, pp. 322-325. DOI:

Next-generation sequencing of a cohort of pulmonary large cell carcinomas reclassified by world health organization 2015 criteria
Driver, BR, Portier, BP, Mody, DR, Deavers, M, Bernicker, EH, Kim, MP, Teh, BS, Santacruz, JF, Kopas, L, Munden, RF & Cagle, PT 2016, Archives of Pathology and Laboratory Medicine, vol 140, no. 4, pp. 312-317. DOI:

Next-generation sequencing and immunotherapy biomarkers: A medical oncology perspective
Bernicker, E 2016, Archives of Pathology and Laboratory Medicine, vol 140, no. 3, pp. 245-248. DOI:

Challenges to biomarker testing for PD-1/PD-L1 checkpoint inhibitors for lung cancer
Cagle, PT & Bernicker, EH 2015, Archives of Pathology and Laboratory Medicine, vol 139, no. 12, pp. 1477-1478. DOI:

A new immunotherapy drug creates a watershed for the surgical pathologist's role in patient care
Cagle, PT & Bernicker, EH 2015, Archives of Pathology and Laboratory Medicine, vol 139, no. 11, pp. 1329-1330. DOI:

Biomarker testing in non-small cell lung cancer: A clinician's perspective
Bernicker, E 2015, Archives of Pathology and Laboratory Medicine, vol 139, no. 4, pp. 448-450. DOI:

Therapy
Bernicker, E , Gaur, P , Desai, S , Teh, BS & Blackmon, SH 2015, . in Diffuse Malignant Mesothelioma. Springer New York, pp. 125-139. DOI:

Cardiac chloroma: Novel presentation and subsequent diagnosis with cardiac magnetic resonance imaging
Attallah, A, Cheong, BYC, Bernicker, E & Wilson, JM 2010, Texas Heart Institute Journal, vol 37, no. 2, pp. 242-243.

Unanticipated diagnoses found at autopsy in an urban public teaching hospital
Bernicker, EH, Atmar, RL, Schaffner, DL & Greenberg, SB 1996, American Journal of the Medical Sciences, vol 311, no. 5, pp. 215-220. DOI:

Case report: transverse myelitis associated with Epstein-Barr virus infection.
Caldas, C, Bernicker, E, Nogare, AD & Luby, JP 1994, American Journal of the Medical Sciences, vol 307, no. 1, pp. 45-48.

The House of God
Shem, S & Bernicker, E 1990, Journal of the American Medical Association, vol 264, no. 13.

Interim meeting report
Bernicker, E 1990, Journal of the American Medical Association, vol 263, no. 5.

Photodynamic therapy triggers cytotoxic drug retained to greater degree by cancer cells.
Bernicker, E 1989, Journal of the American Medical Association, vol 262, no. 18.

Should we legalize drugs?
Bernicker, E 1989, Journal of the American Medical Association, vol 261, no. 16.

Yes and no
Bernicker, E 1989, Journal of the American Medical Association, vol 262, no. 21.

[2]Calcimedins: Purification and production of antibodies
Mathew, JK, Scully, RR, Smith, VL, Bernicker, E & Dedman, JR 1987, Methods in Enzymology, vol 139, no. C, pp. 19-30. DOI: